Photobiomodulation may be the most promising treatment yet for dry age-related macular degeneration. Medscape Medical News
Author: Medscape
Methotrexate Could Reduce the Risk for Retinal Redetachment
Intravitreal injections with methotrexate appear to reduce scar formation after retinal reattachment even in patients with proliferative diabetic retinopathy. Medscape Medical News
Gene Therapy Looks Promising for Diabetic Retinopathy
Genes engineered to make an antivascular endothelial growth factor drug showed encouraging results in a phase 2 trial. Medscape Medical News
Characterizing Astigmatism
Dr Garg discusses a paper from Girish Valluru and colleagues on astigmatism and its effect on cataract surgery. Medscape Ophthalmology
Metformin Shows Potential to Prevent Macular Degeneration
People prescribed the diabetes drug metformin may be less likely to develop age-related macular degeneration. Medscape Medical News
Blood Pressure, Blood Pressure Medications, and Glaucoma
Dr Shuchi Patel and Dr Ruth Williams discuss the relationship between blood pressure and glaucoma, including some simple but useful clinical pearls. Medscape Ophthalmology
Infrared Imaging Explored for Diabetic Retinopathy Screening
Infrared reflectance imaging could provide an opportunity to screen more patients for diabetic retinopathy. Medscape Medical News
ASRS 2022
Read clinically focused news coverage of key developments from ASRS 2022 Medscape Ophthalmology
Bevacizumab First Matches Aflibercept for Diabetic Macular Edema
Results from a randomized trial showed that step therapy for diabetic macular edema with lower-priced bevacizumab followed by pricier aflibercept, when needed, works as well as aflibercept monotherapy. Medscape Medical News
Myopia: A Silent and Growing Epidemic
The proportion of adults who are nearsighted may be as high as 60% by 2050, according to experts. Yet public awareness about risk factors and preventive measures is low. Medscape Medical News
Cataract Surgery: Humana Prior Authorization Plan Raises Concerns
The American Academy of Ophthalmology objects to Humana’s prior authorization plan for cataract surgery in Georgia, citing recent experience with a similar Aetna policy. Medscape Medical News
Topical Eye Meds a Common Cause of Allergic Contact Dermatitis
This type of allergic contact dermatitis is difficult confirm with patch testing, creating the mistaken impression that it’s uncommon. Medscape Medical News
Studies Find Gaps in Radiation Protection for Urologists
Radiation exposure is a workplace hazard for endourologists, and personal protective equipment may not offer sufficient protection, researchers have found. Medscape Medical News
Sympathetic Ophthalmia: How Should We Respond to the Risk?
Ocular trauma or ocular surgery in one eye can lead to loss of vision in the healthy eye. How should ophthalmologists respond to this risk? Medscape Ophthalmology
Updated Uveitis Recommendations Address Treatment Escalation
The recommendations represent an update of 2018 consensus-based recommendations from the SHARE Initiative and the 2019 American College of Rheumatology/Arthritis Foundation guideline. Medscape Medical News
Should Patients Have Cataract Surgery on Both Eyes at Once?
A Cochrane review found that significant clinical differences between the results of simultaneous cataract surgery and those of delayed cataract surgery are unlikely. Medscape Medical News
Dear First-Year Me
What to do when it all feels like too much and you start doubting yourself. Medscape Blogs
Thinning of the Eye’s Retinal Layer a Marker of Cognitive Decline?
Thinning of the eye’s macular retinal nerve fiber layer is linked to cognitive decline in older adults, in new findings that may offer an opportunity for early intervention. Medscape Medical News
Children’s Vision Problems Often Go Undetected
The National Survey of Children’s Health found that in 2016-17 a quarter of children were not regularly screened for vision problems. Kaiser Health News
FDA Approves Brolucizumab for Diabetic Macular Edema
Brolucizumab wins approval for diabetic macular edema but with a warning of retinal vasculitis and retinal vascular occlusion. FDA Approvals